Literature DB >> 23381816

The role of gut-liver axis in the restriction of intrauterine growth in a model of experimental gastroschisis.

Márcia Pereira Bueno1, Frances Lilian Lanhellas Gonçalves, Dioze Guadagnini, Ricardo Barini, Mario José Abdalla Saad, Rodrigo Melo Gallindo, Augusto Frederico Schmidt, Lourenço Sbragia.   

Abstract

PURPOSE: To evaluate the intrauterine growth restriction (IUGR) by the expression of IR-β, IRS-1, IRS-2, IGF-IRβ and Ikappaβ in experimental model of gastroschisis.
METHODS: Pregnant rats at 18.5 days of gestation were submitted to surgery to create experimental fetal gastroschisis (term = 22 days) were divided in three groups: gastroschisis (G), control (C) and sham (S). Fetuses were evaluated for body weight (BW), intestinal (IW), liver (LW) and their relations IW/BW and LW/BW. IR-β and IGF-IRβ receptors, IRS-1 and IRS-2 substrates and Ikappaβ protein were analyzed by western blotting.
RESULTS: BW was lower in G, the IW and IW / BW were greater than C and S (p<0.05) groups. The liver showed no differences between groups. In fetuses with gastroschisis, compared with control fetuses, the expression of IGF-IRβ (p<0.001) and Ikappaβ (p<0.001) increased in the liver and intestine, as well as IR-β (p<0.001) which decreased in both. In contrast to the intestine, IRS-1 (p<0.001) increased in the liver and IRS-2 decreased (p<0.01).
CONCLUSION: The axis of the intestine liver has an important role in inflammation, with consequent changes in the metabolic pathway of glucose can contribute to the IUGR in fetuses with gastroschisis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23381816     DOI: 10.1590/s0102-86502013001300002

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  1 in total

1.  Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model.

Authors:  G H Callejas; R L Figueira; F L L Gonçalves; F A P Volpe; A W Zuardi; J A Crippa; J E Hallak; L Sbragia
Journal:  Braz J Med Biol Res       Date:  2018-03-15       Impact factor: 2.590

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.